Eastern Asia: Market for Medicaments Of Other Antibiotics 2022

Market Size for Medicaments Of Other Antibiotics in Eastern Asia

The East Asian medicaments of other antibiotics market reduced to $X in 2021, waning by -X% against the previous year. Overall, consumption showed a mild shrinkage. As a result, consumption reached the peak level of $X, and then contracted in the following year.

Production of Medicaments Of Other Antibiotics in Eastern Asia

In value terms, medicaments of other antibiotics production declined to $X in 2021 estimated in export price. The total output value increased at an average annual rate of +X% from 2012 to 2021; the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. As a result, production attained the peak level of $X, and then declined in the following year.

Exports of Medicaments Of Other Antibiotics

Exports in Eastern Asia

In 2021, the amount of medicaments of other antibiotics exported in Eastern Asia skyrocketed to X tons, increasing by X% compared with the previous year's figure. Total exports indicated prominent growth from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +X% against 2015 indices. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, medicaments of other antibiotics exports rose sharply to $X in 2021. Total exports indicated a temperate expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, exports increased by +X% against 2014 indices. The most prominent rate of growth was recorded in 2020 when exports increased by X%. Over the period under review, the exports reached the peak figure in 2021 and are likely to see gradual growth in years to come.

Exports by Country

China dominates exports structure, reaching X tons, which was near X% of total exports in 2021. Japan (X tons) and South Korea (X tons) held a minor share of total exports.

China was also the fastest-growing in terms of the medicaments of other antibiotics exports, with a CAGR of +X% from 2012 to 2021. Japan (-X%) and South Korea (-X%) illustrated a downward trend over the same period. percentage points. South Korea (-X p.p.) and Japan (-X p.p.) saw their shares reduced.

In value terms, China ($X) remains the largest medicaments of other antibiotics supplier in Eastern Asia, comprising X% of total exports. The second position in the ranking was held by Japan ($X), with a X% share of total exports.

In China, medicaments of other antibiotics exports expanded at an average annual rate of +X% over the period from 2012-2021. In the other countries, the average annual rates were as follows: Japan (-X% per year) and South Korea (+X% per year).

Export Prices by Country

In 2021, the export price in Eastern Asia amounted to $X per ton, dropping by -X% against the previous year. In general, the export price saw a noticeable decline. The most prominent rate of growth was recorded in 2020 an increase of X%. As a result, the export price reached the peak level of $X per ton, and then fell markedly in the following year.

Prices varied noticeably by the country of origin: the country with the highest price was South Korea ($X per ton), while China ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by South Korea (+X%), while the other leaders experienced more modest paces of growth.

Imports of Medicaments Of Other Antibiotics

Imports in Eastern Asia

In 2021, medicaments of other antibiotics imports in Eastern Asia reduced modestly to X tons, declining by -X% on 2020. Over the period under review, imports showed a perceptible shrinkage. The pace of growth was the most pronounced in 2014 with an increase of X%. Over the period under review, imports attained the peak figure at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments of other antibiotics imports declined modestly to $X in 2021. Total imports indicated a measured increase from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports decreased by -X% against 2018 indices. The pace of growth was the most pronounced in 2017 with an increase of X% against the previous year. The level of import peaked at $X in 2018; however, from 2019 to 2021, imports remained at a lower figure.

Imports by Country

Japan was the major importer of medicaments of other antibiotics in Eastern Asia, with the volume of imports amounting to X tons, which was approx. X% of total imports in 2021. China (X tons) took a X% share (based on physical terms) of total imports, which put it in second place, followed by Taiwan (Chinese) (X%). The following importers - South Korea (X tons) and Hong Kong SAR (X tons) - each amounted to a X% share of total imports.

Imports into Japan decreased at an average annual rate of -X% from 2012 to 2021. At the same time, Taiwan (Chinese) (+X%), South Korea (+X%) and Hong Kong SAR (+X%) displayed positive paces of growth. Moreover, Taiwan (Chinese) emerged as the fastest-growing importer imported in Eastern Asia, with a CAGR of +X% from 2012-2021. China experienced a relatively flat trend pattern. From 2012 to 2021, the share of China and Taiwan (Chinese) increased by +X and +X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, China ($X) constitutes the largest market for imported medicaments of other antibiotics in Eastern Asia, comprising X% of total imports. The second position in the ranking was taken by Hong Kong SAR ($X), with a X% share of total imports. It was followed by Japan, with a X% share.

In China, medicaments of other antibiotics imports increased at an average annual rate of +X% over the period from 2012-2021. The remaining importing countries recorded the following average annual rates of imports growth: Hong Kong SAR (+X% per year) and Japan (-X% per year).

Import Prices by Country

The import price in Eastern Asia stood at $X per ton in 2021, remaining constant against the previous year. Import price indicated a prominent expansion from 2012 to 2021: its price increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, medicaments of other antibiotics import price decreased by -X% against 2018 indices. The most prominent rate of growth was recorded in 2017 when the import price increased by X% against the previous year. Over the period under review, import prices reached the peak figure at $X per ton in 2018; however, from 2019 to 2021, import prices remained at a lower figure.

Prices varied noticeably by the country of destination: the country with the highest price was Hong Kong SAR ($X per ton), while Japan ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by China (+X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :